GOVX – geovax labs, inc. (US:NASDAQ)
Stock Stats
News
GeoVax Labs, Inc. (NASDAQ: GOVX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
GeoVax to Present Clinical Data at Upcoming April Industry Events [Yahoo! Finance]
GeoVax Labs, Inc. (NASDAQ: GOVX) had its price target lowered by analysts at Alliance Global Partners from $15.00 to $8.50. They now have a "buy" rating on the stock.
GeoVax Labs, Inc. (NASDAQ: GOVX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $18.00 price target on the stock.
GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent [Yahoo! Finance]
Form 8-K GeoVax Labs, Inc. For: Apr 11
Form DEF 14A GeoVax Labs, Inc. For: Jun 05
Form 4 GeoVax Labs, Inc. For: Apr 10 Filed by: SPENCER JOHN N JR
Form 4 GeoVax Labs, Inc. For: Apr 10 Filed by: Sharkey John W.
Form 4 GeoVax Labs, Inc. For: Apr 01 Filed by: DODD DAVID A
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.